Melodiol Global Health Stock (OTC: COPHF)

Melodiol Global Health Stock (OTC:COPHF), Trade Ideas

Melodiol Global Health Ltd is engaged in developing, registering, and commercialization of pharmaceutical-grade cannabis and hemp-based nutraceutical products and treatments for human and animal health. Its brands include Mernova: A licensed producer of cannabis products in Canada for sale under the Ritual brand banner. Sierra Sage Herbs: US-based developer of plant-based, beauty, and personal care brands Green Goo, Southern Butter, and Good Goo. impACTIVE: CBD topical products for athletes. Halucenex: Clinical stage psychedelics research and development operation. Creso Pharma Switzerland: CBD-related research, development, and commercialization.

Cannabis

News

Psychedelics

Markets

BETRF

BRAXF

COPHF

PSIL

RED LIGHT HOLLAND CORP by Red Light Holland Corp.

TRUFF

Science Conference In Dubai, UAE Hosts Discussion On Psychedelics Research



Psyched: Dubai Psychedelics Event, Key Receptor Discovered, Drew Barrymore, Oprah&#39;s Guest, Swiss MDMA &amp; More

Penny Stocks

Global

MNMD

Australia-based cannabis and psychedelics company Creso Pharma Ltd. (OTCMKTS: COPHF) inked a Letter of Intent (LOI) with Swiss pharmacy Apotheke Dr.

Creso Pharma&#39;s LOI For Import Of Swiss MDMA And Psilocybin Therapeutics To Australia

Cannabis company Creso Pharma (OTCMKTS: COPHF)’s wholly-owned psychedelics subsidiary Halucenex Life Sciences Inc.

Phase 2 Psilocybin Therapy Trial For Patients With Treatment-Resistant PTSD: Latest Findings

MELODIOL GLOBAL HLTH LTD by MELODIOL GLOBAL HEALTH LTD

Melodiol Global Health Ltd

Former President Donald Trump is reportedly using his ongoing trial as a platform to portray himself as a superhero fighting against the system.
What Happened: Sidney Blumenthal, a former senior adviser to President Bill Clinton, recently <a href="https://www.theguardian.com/commentisfree/2024/apr/23/trump-trial-superhero-shadow">wrote </a>in The Guardian about Trump&#8217;s strategy for his current trial. The ex-president is said to be attempting to flip the script, presenting the prosecution as persecution and using the trial as a campaign trail.
&#8220;Trump has strategized that he could use the trial as his platform to depict himself as the superhero against the system,&#8221; Blumenthal wrote.
Trump&#8217;s approach, as described by Blumenthal, is to position himself as a victim of the &#8220;forces of evil elites&#8221; and inflate his image into a larger-than-life fighter for his followers. He reportedly declared, "I am your retribution!"
However, despite his efforts to control the narrative, Trump&#8217;s actions within the courtroom are restricted. The judge ordered him to sit down when he attempted to leave before adjournment, highlighting the limitations on his &#8220;superhero&#8221; persona.
See Also: <a href="https://www.benzinga.com/news/24/04/38348277/trump-vs-biden-nationwide-poll-shows-key-issue-decidedly-tilts-equation-in-favor-of-one-candidate?itm_source=parsely-api" target="_blank" rel="noreferrer noopener">Trump vs. Biden: Nationwide Poll Shows Key Issue Decidedly Tilts Equation In Favor Of One Candidate</a>
The trial, according to Blumenthal, is more than a legal proceeding for Trump; it is a spectacle that raises the central issue at stake in his cult of personality. Trump&#8217;s promise to testify reveals his understanding of the trial as a public spectacle, despite the potential legal risks.
Trump&#8217;s trial strategy appears to be aimed at maintaining his image as a strongman for his followers. However, the reality of the courtroom and the legal process may prove to be a significant challenge to this narrative.
Why It Matters: Trump&#8217;s potential decision to <a href="https://www.benzinga.com/news/24/04/38369620/trump-taking-the-stand-in-ny-hush-money-trial-would-really-be-a-death-knell-says-ex-doj-attorney-not">testify could be detrimental to his case</a>. Andrew Weissmann, a former Assistant U.S. Attorney and law professor, warned that testifying could pose significant risks for the former president.
Moreover, Trump has been accused of violating a gag order multiple times by Manhattan prosecutors. If found <a href="https://www.benzinga.com/news/24/04/38368871/trump-allegedly-violated-gag-order-10-times-will-hush-money-judge-show-leniency-on-contempt-charges">guilty of breaching the gag order,</a> Trump could face penalties ranging from a warning to a short jail term.
Read Next: <a href="https://www.benzinga.com/general/politics/24/04/38362005/donald-trump-may-soon-receive-36-million-more-djt-shares-key-milestone-ahead?itm_source=parsely-api" target="_blank" rel="noreferrer noopener">Donald Trump May Soon Receive 36 Million More DJT Shares: Key Milestone Ahead</a>
Image via Shutterstock
<div style="font-family: 'Lato', sans-serif">
<div>
<hr style="border: 0;height: 5px;background: #225aa9" />
<div style="background-color: #f5f5f5;background-position: center;background-size: cover;justify-content: center"></div>

 Engineered by Benzinga Neuro, Edited by 
 <a href="https://www.benzinga.com/topic/Pooja-Rajkumari" target="_blank" rel="noopener" style="color: #225aa9;text-decoration: none">Pooja Rajkumari</a> 
 
 
<hr style="border: 0;height: 1px;background: #225aa9" />

 The GPT-4-based Benzinga Neuro content generation system exploits the extensive Benzinga Ecosystem, including native data, APIs, and more to create comprehensive and timely stories for you. 
 <a href="https://www.benzinga.com/author/benzinga-neuro" target="_blank" rel="noopener" style="color: #225aa9;text-decoration: none">Learn more.</a>
 
<hr style="border: 0;height: 5px;background: #225aa9" />
 </div>
</div>

Politics

General

Hush Money Trial Or A 'Superhero' Story? Former Presidential Adviser Reveals Trump's 'Retribution' Plans

<a href="https://www.macrumors.com/2024/04/23/apple-developing-its-own-ai-server-processor/" title="https://www.macrumors.com/2024/04/23/apple-developing-its-own-ai-server-processor/">https://www.macrumors.com/2024/04/23/apple-developing-its-own-ai-server-processor/</a>

AAPL

'Apple Reportedly Developing Its Own Custom Silicon for AI Servers' -Mac Rumors Report

Ford Motor Co&#8216;s F-150 Lightning EV pickup truck seemingly saved a day for children earlier this year. 
What Happened: EV enthusiast Justin Horn in January shared a short video of an F-150 Lightning powering a bounce house after the generator turned off unexpectedly with kids inside. 
The Lightning owner rushed and got it plugged into the pump real quick, Horn wrote in his post. 
<figure class="wp-block-embed is-type-rich is-provider-twitter wp-block-embed-twitter"> 
<div class="wp-block-embed__wrapper">
<blockquote class="twitter-tweet" data-width="500" data-dnt="true">Told my buddy to switch the bounce house over to his <a href="https://twitter.com/Ford?ref_src=twsrc%5Etfw">@Ford</a> Lighting, he was planning to do it anyway &amp; I was going to take a funny "staged" video… but then the generator turned off unexpectedly with kids inside. He rushed over and got it plugged really quick. <a href="https://twitter.com/jimfarley98?ref_src=twsrc%5Etfw">@jimfarley98</a> <a href="https://t.co/VssoULsACg">pic.twitter.com/VssoULsACg</a>
&mdash; Justin Horn (@justin_horn) <a href="https://twitter.com/justin_horn/status/1749146318591725686?ref_src=twsrc%5Etfw">January 21, 2024</a></blockquote>
<script async src="https://platform.twitter.com/widgets.js" charset="utf-8"></script></div>
</figure>
The Lightning has power outlets in the cab, bed, and frunk of the vehicle. In the video, the house is seemingly connected to the power outlet in the truck bed. 
The video was shared by Ford CEO Jim Farley on Monday.
Why It Matters: The Lightning can even power homes in case of a power outage if the home is properly equipped. It&nbsp;<a href="https://www.benzinga.com/news/22/03/26095811/ford-ties-up-with-pg-e-to-pilot-bidirectional-ev-charging-as-power-source-for-homes" target="_blank" rel="noreferrer noopener">can power homes</a> for up to three days or even 10 if usage is properly rationed, according to the automaker.
Lightning&#8217;s key rival Cybertruck can also power tools. The Cybertruck is the<a href="https://www.benzinga.com/news/24/03/37814648/own-a-cybertruck-it-can-soon-power-your-home-says-tesla-exec"> only Tesla equipped with powershare</a> to charge homes or other EVs. 
Check out more of Benzinga's Future Of Mobility coverage by&nbsp;<a href="http://www.benzinga.com/topic/mobility" target="_blank" rel="noreferrer noopener">following this link</a>.
Read More:&nbsp;<a href="https://www.benzinga.com/news/24/04/38373389/tesla-ceo-elon-musk-takes-swipe-at-waymo-says-cybertruck-might-be-needed-for-robotaxis-in-san-franci">Tesla CEO Elon Musk Takes Swipe At Waymo, Says Cybertruck Might Be Needed For Robotaxis In San Francisco Amid Vandalism Frenzy</a>
Photo via Shutterstock

Social Media

Tech

Ford CEO Jim Farley Reposts Video Of F-150 Lightning Powering A Bounce House After Generator Failed

BMO Capital analyst John McNulty maintains PPG Indus (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/PPG#NYSE">PPG</a>) with a Outperform and lowers the price target from $168 to $165.

Price Target

Analyst Ratings

BMO Capital Maintains Outperform on PPG Indus, Lowers Price Target to $165

BMO Capital analyst Jeremy Mccrea maintains PrairieSky Royalty (TSX:<a class="ticker" href="https://www.benzinga.com/stock/PSK#TSX">PSK</a>) with a Outperform and raises the price target from C$30 to C$33.

TSX:PSK

BMO Capital Maintains Outperform on PrairieSky Royalty, Raises Price Target to C$33

WIIM

LKQ shares are trading lower after the company reported a Q1 earnings miss and cut its FY24 outlook.

JMP Securities analyst Joe Goodwin reiterates Model N (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/MODN#NYSE">MODN</a>) with a Market Perform.

Reiteration

MODN

JMP Securities Reiterates Market Perform on Model N

Riot Platforms (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/RIOT#NASDAQ">RIOT</a>) has outperformed the market over the past 5 years by 6.52% on an annualized basis producing an average annual return of 17.86%. Currently, Riot Platforms has a market capitalization of $2.99 billion. 
Buying $100 In RIOT: If an investor had bought $100 of RIOT stock 5 years ago, it would be worth $225.23 today based on a price of $11.78 for RIOT at the time of writing.
<h3>Riot Platforms's Performance Over Last 5 Years</h3>
<img src="https://www.benzinga.com/files/images/story/2024/1713880851_0.png" alt="comp_fig" />
Finally -- what's the point of all this? The key insight to take from this article is to note how much of a difference compounded returns can make in your cash growth over a period of time.
This article was generated by Benzinga's automated content engine and reviewed by an editor.

Trading Ideas

RIOT

$100 Invested In Riot Platforms 5 Years Ago Would Be Worth This Much Today

Meta Platforms (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/META#NASDAQ">META</a>) has outperformed the market over the past 10 years by 13.43% on an annualized basis producing an average annual return of 23.78%. Currently, Meta Platforms has a market capitalization of $1.24 trillion. 
Buying $100 In META: If an investor had bought $100 of META stock 10 years ago, it would be worth $874.40 today based on a price of $490.68 for META at the time of writing.
<h3>Meta Platforms's Performance Over Last 10 Years</h3>
<img src="https://www.benzinga.com/files/images/story/2024/1713880846_0.png" alt="comp_fig" />
Finally -- what's the point of all this? The key insight to take from this article is to note how much of a difference compounded returns can make in your cash growth over a period of time.
This article was generated by Benzinga's automated content engine and reviewed by an editor.

Here's How Much You Would Have Made Owning Meta Platforms Stock In The Last 10 Years

Macro Economic Events

Econ #s

Economics

USA New Home Sales (MoM) For March 8.8% Vs -5.1% Prior

In the preceding three months, 4 analysts have released ratings for Addus HomeCare (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/ADUS#NASDAQ">ADUS</a>), presenting a wide array of perspectives from bullish to bearish.
The table below provides a snapshot of their recent ratings, showcasing how sentiments have evolved over the past 30 days and comparing them to the preceding months.
<table>
<thead>
<tr>
<th></th>
<th style="text-align: right;">Bullish</th>
<th style="text-align: right;">Somewhat Bullish</th>
<th style="text-align: right;">Indifferent</th>
<th style="text-align: right;">Somewhat Bearish</th>
<th style="text-align: right;">Bearish</th>
</tr>
</thead>
<tbody>
<tr>
<td>Total Ratings</td>
<td style="text-align: right;">0</td>
<td style="text-align: right;">2</td>
<td style="text-align: right;">1</td>
<td style="text-align: right;">1</td>
<td style="text-align: right;">0</td>
</tr>
<tr>
<td>Last 30D</td>
<td style="text-align: right;">0</td>
<td style="text-align: right;">0</td>
<td style="text-align: right;">0</td>
<td style="text-align: right;">1</td>
<td style="text-align: right;">0</td>
</tr>
<tr>
<td>1M Ago</td>
<td style="text-align: right;">0</td>
<td style="text-align: right;">1</td>
<td style="text-align: right;">0</td>
<td style="text-align: right;">0</td>
<td style="text-align: right;">0</td>
</tr>
<tr>
<td>2M Ago</td>
<td style="text-align: right;">0</td>
<td style="text-align: right;">1</td>
<td style="text-align: right;">1</td>
<td style="text-align: right;">0</td>
<td style="text-align: right;">0</td>
</tr>
<tr>
<td>3M Ago</td>
<td style="text-align: right;">0</td>
<td style="text-align: right;">0</td>
<td style="text-align: right;">0</td>
<td style="text-align: right;">0</td>
<td style="text-align: right;">0</td>
</tr>
</tbody>
</table>
The 12-month price targets assessed by analysts reveal further insights, featuring an average target of $97.75, a high estimate of $118.00, and a low estimate of $83.00. A negative shift in sentiment is evident as analysts have decreased the average price target by 17.16%. 
<img src="https://www.benzinga.com/files/images/story/2024/1713880831_0.png" alt="price target chart" />
<h2>Decoding Analyst Ratings: A Detailed Look</h2>
The standing of Addus HomeCare among financial experts is revealed through an in-depth exploration of recent analyst actions. The summary below outlines key analysts, their recent evaluations, and adjustments to ratings and price targets.
<table>
<thead>
<tr>
<th>Analyst</th>
<th>Analyst Firm</th>
<th>Action Taken</th>
<th>Rating</th>
<th>Current Price Target</th>
<th>Prior Price Target</th>
</tr>
</thead>
<tbody>
<tr>
<td>Andrew Mok</td>
<td>Barclays</td>
<td>Announces</td>
<td>Underweight</td>
<td>$83.00</td>
<td>-</td>
</tr>
<tr>
<td>Michael Wiederhorn</td>
<td>Oppenheimer</td>
<td>Maintains</td>
<td>Outperform</td>
<td>$118.00</td>
<td>$118.00</td>
</tr>
<tr>
<td>Andrew Mok</td>
<td>Barclays</td>
<td>Announces</td>
<td>Equal-Weight</td>
<td>$88.00</td>
<td>-</td>
</tr>
<tr>
<td>Ben Hendrix</td>
<td>RBC Capital</td>
<td>Maintains</td>
<td>Outperform</td>
<td>$102.00</td>
<td>-</td>
</tr>
</tbody>
</table>
<h3>Key Insights:</h3>
<ul>
<li>Action Taken: Responding to changing market dynamics and company performance, analysts update their recommendations. Whether they 'Maintain', 'Raise', or 'Lower' their stance, it signifies their response to recent developments related to Addus HomeCare. This offers insight into analysts' perspectives on the current state of the company.</li>
<li>Rating: Delving into assessments, analysts assign qualitative values, from 'Outperform' to 'Underperform'. These ratings communicate expectations for the relative performance of Addus HomeCare compared to the broader market.</li>
<li>Price Targets: Analysts predict movements in price targets, offering estimates for Addus HomeCare's future value. Examining the current and prior targets offers insights into analysts' evolving expectations.</li>
</ul>
Analyzing these analyst evaluations alongside relevant financial metrics can provide a comprehensive view of Addus HomeCare's market position. Stay informed and make data-driven decisions with the assistance of our Ratings Table.
<a href="https://www.benzinga.com/quote/ADUS/analyst-ratings?utm_source=Benzinga Insights">Stay up to date on Addus HomeCare analyst ratings.</a>
If you are interested in following small-cap stock news and performance <a href="https://www.benzinga.com/news/small-cap">you can start by tracking it here</a>.
<h2>Get to Know Addus HomeCare Better</h2>
Addus HomeCare Corp is engaged in the provision of in-home personal care services. It operates through the segments such as Personal care segment, which is a key revenue driver, provides non-medical assistance with activities of daily living, primarily to persons who are at risk of hospitalization or institutionalization, such as the elderly, chronically ill and disabled. The Hospice segment provides physical, emotional and spiritual care for people who are terminally ill and their families. Its Home health segment provides services that are primarily medical in nature to those individuals who may require assistance during an illness or after surgery.
<h3>Addus HomeCare: Financial Performance Dissected</h3>
Market Capitalization: Indicating a reduced size compared to industry averages, the company's market capitalization poses unique challenges.
Revenue Growth: Addus HomeCare displayed positive results in 3 months. As of 31 December, 2023, the company achieved a solid revenue growth rate of approximately 11.86%. This indicates a notable increase in the company's top-line earnings. In comparison to its industry peers, the company trails behind with a growth rate lower than the average among peers in the Health Care sector.
Net Margin: The company's net margin is a standout performer, exceeding industry averages. With an impressive net margin of 7.08%, the company showcases strong profitability and effective cost control.
Return on Equity (ROE): Addus HomeCare's ROE surpasses industry standards, highlighting the company's exceptional financial performance. With an impressive 2.81% ROE, the company effectively utilizes shareholder equity capital.
Return on Assets (ROA): Addus HomeCare's financial strength is reflected in its exceptional ROA, which exceeds industry averages. With a remarkable ROA of 1.9%, the company showcases efficient use of assets and strong financial health.
Debt Management: Addus HomeCare's debt-to-equity ratio is below the industry average. With a ratio of 0.25, the company relies less on debt financing, maintaining a healthier balance between debt and equity, which can be viewed positively by investors.
<h2>The Basics of Analyst Ratings</h2>
Analysts work in banking and financial systems and typically specialize in reporting for stocks or defined sectors. Analysts may attend company conference calls and meetings, research company financial statements, and communicate with insiders to publish "analyst ratings" for stocks. Analysts typically rate each stock once per quarter.
Some analysts publish their predictions for metrics such as growth estimates, earnings, and revenue to provide additional guidance with their ratings. When using analyst ratings, it is important to keep in mind that stock and sector analysts are also human and are only offering their opinions to investors.
If you want to keep track of which analysts are outperforming others, you can view updated analyst ratings along withanalyst success scores in <a href="https://benzinga.grsm.io/register174">Benzinga Pro</a>.
This article was generated by Benzinga's automated content engine and reviewed by an editor.

ADUS

Cracking The Code: Understanding Analyst Reviews For Addus HomeCare

Eastern Bankshares's (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/EBC#NYSE">EBC</a>) short percent of float has risen 3.75% since its last report. The company recently reported that it has 4.84 million shares sold short, which is 2.77% of all regular shares that are available for trading. Based on its trading volume, it would take traders 6.16 days to cover their short positions on average.
<h3>Why Short Interest Matters</h3>
Short interest is the number of shares that have been sold short but have not yet been covered or closed out. <a href="https://www.benzinga.com/money/how-to-short-a-stock/">Short selling</a> is when a trader sells shares of a company they do not own, with the hope that the price will fall. Traders make money from short selling if the price of the stock falls and they lose if it rises.
Short interest is important to track because it can act as an indicator of market sentiment towards a particular stock. An increase in short interest can signal that investors have become more bearish, while a decrease in short interest can signal they have become more bullish.
See Also: <a href="https://www.benzinga.com/short-interest">List of the most shorted stocks</a>
<h3>Eastern Bankshares Short Interest Graph (3 Months)</h3>
<img src="https://www.benzinga.com/files/images/story/2024/1713880829_0.png" alt="short_fig" />
As you can see from the chart above the percentage of shares that are sold short for Eastern Bankshares has grown since its last report. This does not mean that the stock is going to fall in the near-term but traders should be aware that more shares are being shorted.
<h3>Comparing Eastern Bankshares's Short Interest Against Its Peers</h3>
Peer comparison is a popular technique amongst analysts and investors for gauging how well a company is performing. A company's peer is another company that has similar characteristics to it, such as industry, size, age, and financial structure. You can find a company's peer group by reading its 10-K, proxy filing, or by doing your own similarity analysis.
According to <a href="https://pro.benzinga.com/">Benzinga Pro</a>, Eastern Bankshares's peer group average for short interest as a percentage of float is 5.13%, which means the company has less short interest than most of its peers.
Did you know that increasing short interest can actually be bullish for a stock? <a href="https://www.benzinga.com/money/how-to-make-money-on-a-short-squeeze/">This post by Benzinga Money explains how you can profit from it.</a>
This article was generated by Benzinga's automated content engine and was reviewed by an editor.

Short Sellers

Short Ideas

How Is The Market Feeling About Eastern Bankshares?

Hamilton Lane's (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/HLNE#NYSE">HLNE</a>) short percent of float has fallen 11.83% since its last report. The company recently reported that it has 876 thousand shares sold short, which is 2.31% of all regular shares that are available for trading. Based on its trading volume, it would take traders 4.21 days to cover their short positions on average.
<h3>Why Short Interest Matters</h3>
Short interest is the number of shares that have been sold short but have not yet been covered or closed out. <a href="https://www.benzinga.com/money/how-to-short-a-stock/">Short selling</a> is when a trader sells shares of a company they do not own, with the hope that the price will fall. Traders make money from short selling if the price of the stock falls and they lose if it rises.
Short interest is important to track because it can act as an indicator of market sentiment towards a particular stock. An increase in short interest can signal that investors have become more bearish, while a decrease in short interest can signal they have become more bullish.
See Also: <a href="https://www.benzinga.com/short-interest">List of the most shorted stocks</a>
<h3>Hamilton Lane Short Interest Graph (3 Months)</h3>
<img src="https://www.benzinga.com/files/images/story/2024/1713880823_0.png" alt="short_fig" />
As you can see from the chart above the percentage of shares that are sold short for Hamilton Lane has declined since its last report. This does not mean that the stock is going to rise in the near-term but traders should be aware that less shares are being shorted.
<h3>Comparing Hamilton Lane's Short Interest Against Its Peers</h3>
Peer comparison is a popular technique amongst analysts and investors for gauging how well a company is performing. A company's peer is another company that has similar characteristics to it, such as industry, size, age, and financial structure. You can find a company's peer group by reading its 10-K, proxy filing, or by doing your own similarity analysis.
According to <a href="https://pro.benzinga.com/">Benzinga Pro</a>, Hamilton Lane's peer group average for short interest as a percentage of float is 2.71%, which means the company has less short interest than most of its peers.
Did you know that increasing short interest can actually be bullish for a stock? <a href="https://www.benzinga.com/money/how-to-make-money-on-a-short-squeeze/">This post by Benzinga Money explains how you can profit from it.</a>
This article was generated by Benzinga's automated content engine and was reviewed by an editor.

HLNE

Looking Into Hamilton Lane's Recent Short Interest

Five Below (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/FIVE#NASDAQ">FIVE</a>) has been analyzed by 17 analysts in the last three months, revealing a diverse range of perspectives from bullish to bearish.
Summarizing their recent assessments, the table below illustrates the evolving sentiments in the past 30 days and compares them to the preceding months.
<table>
<thead>
<tr>
<th></th>
<th style="text-align: right;">Bullish</th>
<th style="text-align: right;">Somewhat Bullish</th>
<th style="text-align: right;">Indifferent</th>
<th style="text-align: right;">Somewhat Bearish</th>
<th style="text-align: right;">Bearish</th>
</tr>
</thead>
<tbody>
<tr>
<td>Total Ratings</td>
<td style="text-align: right;">4</td>
<td style="text-align: right;">9</td>
<td style="text-align: right;">4</td>
<td style="text-align: right;">0</td>
<td style="text-align: right;">0</td>
</tr>
<tr>
<td>Last 30D</td>
<td style="text-align: right;">0</td>
<td style="text-align: right;">0</td>
<td style="text-align: right;">1</td>
<td style="text-align: right;">0</td>
<td style="text-align: right;">0</td>
</tr>
<tr>
<td>1M Ago</td>
<td style="text-align: right;">0</td>
<td style="text-align: right;">2</td>
<td style="text-align: right;">0</td>
<td style="text-align: right;">0</td>
<td style="text-align: right;">0</td>
</tr>
<tr>
<td>2M Ago</td>
<td style="text-align: right;">4</td>
<td style="text-align: right;">6</td>
<td style="text-align: right;">2</td>
<td style="text-align: right;">0</td>
<td style="text-align: right;">0</td>
</tr>
<tr>
<td>3M Ago</td>
<td style="text-align: right;">0</td>
<td style="text-align: right;">1</td>
<td style="text-align: right;">1</td>
<td style="text-align: right;">0</td>
<td style="text-align: right;">0</td>
</tr>
</tbody>
</table>
In the assessment of 12-month price targets, analysts unveil insights for Five Below, presenting an average target of $211.29, a high estimate of $245.00, and a low estimate of $170.00. Observing a downward trend, the current average is 5.48% lower than the prior average price target of $223.53. 
<img src="https://www.benzinga.com/files/images/story/2024/1713880821_0.png" alt="price target chart" />
<h2>Exploring Analyst Ratings: An In-Depth Overview</h2>
The perception of Five Below by financial experts is analyzed through recent analyst actions. The following summary presents key analysts, their recent evaluations, and adjustments to ratings and price targets.
<table>
<thead>
<tr>
<th>Analyst</th>
<th>Analyst Firm</th>
<th>Action Taken</th>
<th>Rating</th>
<th>Current Price Target</th>
<th>Prior Price Target</th>
</tr>
</thead>
<tbody>
<tr>
<td>Matthew Boss</td>
<td>JP Morgan</td>
<td>Lowers</td>
<td>Neutral</td>
<td>$170.00</td>
<td>$215.00</td>
</tr>
<tr>
<td>Michael Montani</td>
<td>Evercore ISI Group</td>
<td>Lowers</td>
<td>Outperform</td>
<td>$225.00</td>
<td>$230.00</td>
</tr>
<tr>
<td>Chuck Grom</td>
<td>Gordon Haskett</td>
<td>Lowers</td>
<td>Accumulate</td>
<td>$200.00</td>
<td>$210.00</td>
</tr>
<tr>
<td>Seth Sigman</td>
<td>Barclays</td>
<td>Lowers</td>
<td>Overweight</td>
<td>$214.00</td>
<td>$225.00</td>
</tr>
<tr>
<td>Scot Ciccarelli</td>
<td>Truist Securities</td>
<td>Lowers</td>
<td>Buy</td>
<td>$204.00</td>
<td>$214.00</td>
</tr>
<tr>
<td>Jeremy Hamblin</td>
<td>Craig-Hallum</td>
<td>Lowers</td>
<td>Hold</td>
<td>$187.00</td>
<td>$195.00</td>
</tr>
<tr>
<td>Simeon Gutman</td>
<td>Morgan Stanley</td>
<td>Lowers</td>
<td>Overweight</td>
<td>$210.00</td>
<td>$225.00</td>
</tr>
<tr>
<td>Michael Lasser</td>
<td>UBS</td>
<td>Lowers</td>
<td>Buy</td>
<td>$245.00</td>
<td>$270.00</td>
</tr>
<tr>
<td>Michael Montani</td>
<td>Evercore ISI Group</td>
<td>Lowers</td>
<td>Outperform</td>
<td>$230.00</td>
<td>$240.00</td>
</tr>
<tr>
<td>David Bellinger</td>
<td>Mizuho</td>
<td>Lowers</td>
<td>Buy</td>
<td>$215.00</td>
<td>$225.00</td>
</tr>
<tr>
<td>George Kelly</td>
<td>Wells Fargo</td>
<td>Lowers</td>
<td>Equal-Weight</td>
<td>$180.00</td>
<td>$200.00</td>
</tr>
<tr>
<td>Matthew Korn</td>
<td>JP Morgan</td>
<td>Lowers</td>
<td>Overweight</td>
<td>$215.00</td>
<td>$222.00</td>
</tr>
<tr>
<td>Joseph Feldman</td>
<td>Telsey Advisory Group</td>
<td>Lowers</td>
<td>Outperform</td>
<td>$220.00</td>
<td>$230.00</td>
</tr>
<tr>
<td>David Bellinger</td>
<td>Mizuho</td>
<td>Announces</td>
<td>Buy</td>
<td>$225.00</td>
<td>-</td>
</tr>
<tr>
<td>Joseph Feldman</td>
<td>Telsey Advisory Group</td>
<td>Maintains</td>
<td>Outperform</td>
<td>$230.00</td>
<td>-</td>
</tr>
<tr>
<td>Brian Nagel</td>
<td>Oppenheimer</td>
<td>Lowers</td>
<td>Perform</td>
<td>$200.00</td>
<td>$235.00</td>
</tr>
<tr>
<td>Matthew Korn</td>
<td>JP Morgan</td>
<td>Raises</td>
<td>Overweight</td>
<td>$222.00</td>
<td>$217.00</td>
</tr>
</tbody>
</table>
<h3>Key Insights:</h3>
<ul>
<li>Action Taken: Analysts respond to changes in market conditions and company performance, frequently updating their recommendations. Whether they 'Maintain', 'Raise' or 'Lower' their stance, it reflects their reaction to recent developments related to Five Below. This information offers a snapshot of how analysts perceive the current state of the company.</li>
<li>Rating: Providing a comprehensive analysis, analysts offer qualitative assessments, ranging from 'Outperform' to 'Underperform'. These ratings reflect expectations for the relative performance of Five Below compared to the broader market.</li>
<li>Price Targets: Analysts explore the dynamics of price targets, providing estimates for the future value of Five Below's stock. This examination reveals shifts in analysts' expectations over time.</li>
</ul>
Assessing these analyst evaluations alongside crucial financial indicators can provide a comprehensive overview of Five Below's market position. Stay informed and make well-judged decisions with the assistance of our Ratings Table.
<a href="https://www.benzinga.com/quote/FIVE/analyst-ratings?utm_source=Benzinga Insights">Stay up to date on Five Below analyst ratings.</a>
<h2>Unveiling the Story Behind Five Below</h2>
Five Below Inc is a specialty value retailer offering merchandise targeted at the tween and teen demographic. The Company's edited assortment of products includes select brands and licensed merchandise.
<h3>Five Below's Economic Impact: An Analysis</h3>
Market Capitalization Analysis: With an elevated market capitalization, the company stands out above industry averages, showcasing substantial size and market acknowledgment.
Revenue Growth: Five Below's revenue growth over a period of 3 months has been noteworthy. As of 31 January, 2024, the company achieved a revenue growth rate of approximately 19.15%. This indicates a substantial increase in the company's top-line earnings. As compared to competitors, the company surpassed expectations with a growth rate higher than the average among peers in the Consumer Discretionary sector.
Net Margin: Five Below's financial strength is reflected in its exceptional net margin, which exceeds industry averages. With a remarkable net margin of 15.12%, the company showcases strong profitability and effective cost management.
Return on Equity (ROE): Five Below's financial strength is reflected in its exceptional ROE, which exceeds industry averages. With a remarkable ROE of 13.65%, the company showcases efficient use of equity capital and strong financial health.
Return on Assets (ROA): Five Below's financial strength is reflected in its exceptional ROA, which exceeds industry averages. With a remarkable ROA of 5.37%, the company showcases efficient use of assets and strong financial health.
Debt Management: With a below-average debt-to-equity ratio of 1.1, Five Below adopts a prudent financial strategy, indicating a balanced approach to debt management.
<h2>Understanding the Relevance of Analyst Ratings</h2>
Ratings come from analysts, or specialists within banking and financial systems that report for specific stocks or defined sectors (typically once per quarter for each stock). Analysts usually derive their information from company conference calls and meetings, financial statements, and conversations with important insiders to reach their decisions.
Analysts may supplement their ratings with predictions for metrics like growth estimates, earnings, and revenue, offering investors a more comprehensive outlook. However, investors should be mindful that analysts, like any human, can have subjective perspectives influencing their forecasts.
This article was generated by Benzinga's automated content engine and reviewed by an editor.

FIVE

The Analyst Landscape: 17 Takes On Five Below

USA New Home Sales For March 693K Vs 668K Est.; 637K Prior

First American Financial's (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/FAF#NYSE">FAF</a>) short percent of float has fallen 34.83% since its last report. The company recently reported that it has 1.16 million shares sold short, which is 1.16% of all regular shares that are available for trading. Based on its trading volume, it would take traders 1.62 days to cover their short positions on average.
<h3>Why Short Interest Matters</h3>
Short interest is the number of shares that have been sold short but have not yet been covered or closed out. <a href="https://www.benzinga.com/money/how-to-short-a-stock/">Short selling</a> is when a trader sells shares of a company they do not own, with the hope that the price will fall. Traders make money from short selling if the price of the stock falls and they lose if it rises.
Short interest is important to track because it can act as an indicator of market sentiment towards a particular stock. An increase in short interest can signal that investors have become more bearish, while a decrease in short interest can signal they have become more bullish.
See Also: <a href="https://www.benzinga.com/short-interest">List of the most shorted stocks</a>
<h3>First American Financial Short Interest Graph (3 Months)</h3>
<img src="https://www.benzinga.com/files/images/story/2024/1713880818_0.png" alt="short_fig" />
As you can see from the chart above the percentage of shares that are sold short for First American Financial has declined since its last report. This does not mean that the stock is going to rise in the near-term but traders should be aware that less shares are being shorted.
<h3>Comparing First American Financial's Short Interest Against Its Peers</h3>
Peer comparison is a popular technique amongst analysts and investors for gauging how well a company is performing. A company's peer is another company that has similar characteristics to it, such as industry, size, age, and financial structure. You can find a company's peer group by reading its 10-K, proxy filing, or by doing your own similarity analysis.
According to <a href="https://pro.benzinga.com/">Benzinga Pro</a>, First American Financial's peer group average for short interest as a percentage of float is 1.75%, which means the company has less short interest than most of its peers.
Did you know that increasing short interest can actually be bullish for a stock? <a href="https://www.benzinga.com/money/how-to-make-money-on-a-short-squeeze/">This post by Benzinga Money explains how you can profit from it.</a>
This article was generated by Benzinga's automated content engine and was reviewed by an editor.

(FAF) - Analyzing First American Financial's Short Interest

Keybanc analyst Sophie Karp downgrades Sunnova Energy Intl (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/NOVA#NYSE">NOVA</a>) from Overweight to Sector Weight.

Downgrades

NOVA

Keybanc Downgrades Sunnova Energy Intl to Sector Weight

Shares of life sciences tools stocks are trading higher following strong earnings from Danaher.

Loop Capital analyst Yun Kim downgrades Matterport (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/MTTR#NASDAQ">MTTR</a>) from Buy to Hold and raises the price target from $5 to $5.5.

MTTR

Loop Capital Downgrades Matterport to Hold, Raises Price Target to $5.5

RNAC

Cartesian Therapeutics shares are trading higher after Leerink Partners initiated coverage on the stock with an Outperform rating and announced a $39 price target.

Melodiol Global Health Limited (AU:ME1) has released an update. Melodiol Global Health Limited has announced the application for quotation of 101,3...

Melodiol Global Health Applies for ASX Listing

Melodiol Global Health Limited (AU:ME1) has released an update. Melodiol Global Health Limited, identified by ASX issuer code ME1, has announced th...

Melodiol Global Applies for New Securities Quotation

Melodiol Global Health Limited (AU:ME1) has released an update. Melodiol Global Health Limited has announced a new securities issue that includes o...

Melodiol's New Securities Issue Announcement

Melodiol Global Health Limited (AU:ME1) has released an update. Melodiol Global Health Limited confidently asserts its compliance with relevant acc...

Melodiol Global Outlines Financial Health and Compliance

Melodiol Global Health Limited (AU:ME1) has released an update. Melodiol Global Health Limited has announced a new securities issue of 170 million ...

Melodiol Announces Major New Securities Issue

Melodiol Global Health Limited (AU:ME1) has released an update. Melodiol Global Health Limited has announced a new securities issuance, proposing t...

Melodiol Global Plans New Share Issuance

Melodiol Global Health Limited (AU:ME1) has released an update. Melodiol Global Health Limited has applied for the quotation of 135,294,117 newly i...

Melodiol Global Seeks ASX Quotation for New Shares

Melodiol Global Health Limited (AU:ME1) has released an update. Melodiol Global Health Limited, a company specializing in plant-based health produc...

Melodiol Issues Shares, Affirms Transparency

Melodiol Global Health Limited (AU:ME1) has released an update. Melodiol Global Health Limited has announced an update to its previously declared s...